bosentan anhydrous has been researched along with Aging in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akita, C; Hirono, K; Ichida, F; Ishida, K; Kohno, H; Nakamura, T; Ozawa, S; Taguchi, M; Yoshimura, N | 1 |
| Breitkreutz, J; Läer, S; Ramusovic, S | 1 |
| Edge, G; Hennessy, M; Kelso, EJ; McDermott, BJ; Siah, WF; Song, G; Spiers, JP | 1 |
| Lüscher, TF; Seo, B | 1 |
| Bauer, C; Diekmann, F; Distler, A; Gretz, N; Hocher, B; Koppenhagen, K; Rohmeiss, P; Schiller, S; Vogt, V; Zart, R | 1 |
| Yamazaki, T; Yazaki, Y | 1 |
| Zimmermann, M | 1 |
| Baylis, C; Engels, K; Greenfeld, Z; Samsell, L | 1 |
| Besse, S; Boucher, F; Bulteau, AL; de Leiris, J; Le Page, C; Riou, B; Swynghedauw, B; Tanguy, S | 1 |
1 review(s) available for bosentan anhydrous and Aging
| Article | Year |
|---|---|
[The ideal dosage form for clinical study. Bosentan in pediatric patients].
Topics: Aging; Antihypertensive Agents; Bosentan; Chemistry, Pharmaceutical; Child; Dosage Forms; Humans; Hypertension, Pulmonary; Sulfonamides | 2010 |
1 trial(s) available for bosentan anhydrous and Aging
| Article | Year |
|---|---|
Endothelin in cerebral vasospasm. Clinical and experimental results.
Topics: Adolescent; Adult; Aged; Aging; Animals; Bosentan; Dogs; Endothelin Receptor Antagonists; Endothelin-1; Endothelin-3; Endothelins; Female; Hematoma; Humans; Ischemic Attack, Transient; Male; Middle Aged; Protein Precursors; Sulfonamides | 1997 |
7 other study(ies) available for bosentan anhydrous and Aging
| Article | Year |
|---|---|
Plasma concentrations of tadalafil in children with pulmonary arterial hypertension.
Topics: Adolescent; Aging; Antihypertensive Agents; Bosentan; Carbolines; Child; Child, Preschool; Female; Humans; Hypertension, Pulmonary; Infant; Male; Sulfonamides; Tadalafil; Vasodilator Agents | 2014 |
Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
Topics: Aging; Animals; Antihypertensive Agents; Aorta, Thoracic; Blotting, Western; Bosentan; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelium, Vascular; Enzyme Precursors; Gelatinases; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinases; Metalloendopeptidases; Microscopy, Fluorescence; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Reference Standards; Sulfonamides | 2005 |
ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
Topics: Aging; Animals; Azepines; Bosentan; Drug Interactions; Endothelin Receptor Antagonists; Endothelins; Indoles; Male; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Renal Artery; Species Specificity; Sulfonamides; Vasoconstriction; Vasoconstrictor Agents; Viper Venoms | 1995 |
Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan.
Topics: Aging; Animals; Autoradiography; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Endothelins; Glomerular Filtration Rate; Heart Rate; Hemodynamics; Kidney; Male; Peptide Fragments; Peptides, Cyclic; Protein Binding; Rats; Rats, Inbred WKY; Receptors, Endothelin; Renal Circulation; Sodium; Sulfonamides; Urination; Vascular Resistance | 1995 |
Reversing congestive heart failure with endothelin receptor antagonists.
Topics: Aging; Angiotensin II; Animals; Bosentan; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Heart Failure; Humans; Mice; Mice, Transgenic; Rabbits; Receptors, Endothelin; Sulfonamides | 1997 |
The role of endothelin in the age dependent increase in renal vascular resistance in the rat kidney.
Topics: Aging; Animals; Blood Pressure; Bosentan; Endothelin Receptor Antagonists; Endothelins; Glomerular Filtration Rate; Kidney; Male; Rats; Rats, Sprague-Dawley; Renal Plasma Flow; Sulfonamides; Vascular Resistance | 1998 |
Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats.
Topics: Acetylcholine; Aging; Animals; Aorta, Thoracic; Bosentan; Coronary Circulation; Coronary Vessels; Endothelin Receptor Antagonists; Hypoxia; In Vitro Techniques; Male; Myocardial Ischemia; Nitroprusside; Oxygen; Phenylephrine; Rats; Rats, Wistar; Reperfusion Injury; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |